Podcasts about wayn

After a week away, the boys are back with a real beau­ty of an episode — you might say we real­ly nailed this one! That's right we're yakking about one of the biggest draft busts of all time, #64 Nail Yakapov! He may have went first over­all in 2012, but he was out of the league 6 years lat­er after bounc­ing from the Oil­ers to the Blues and final­ly to the Avs. He returned to moth­er Rus­sia and have carved him­self out a nice career, still play­ing today… And speak­ing of Russ­ian play­ers who have done okay for them­selves, we talk exten­sive­ly about the Great 8 — the NHL's new all time lead­ing goal scor­er, Alex Ovechkin! Ol' Ovi tied Wayn­er's long­stand­ing accom­plish­ment with 2 against the Black­hawks, and then scored num­ber 895 in a loss against the Islanders while we recorded. Final­ly, we've got a trio of stat lines of the week, plus we talk about oth­er records that might nev­er be broken.

Actor Josh Brener has auditioned hundreds of times, but I'm proud to say I witnessed his very first audition! In addition to sharing our memories of this momentous occasion, Josh and I discussed his journey from school plays to the TV and movie screen. Recorded on 3/29/25.Note to listener: Even with the edits, this episode turned out to be longer than usual. I would have made it into a two-parter, but I'm not tech-savvy enough to know how to do that. Feel free to listen in sections.   

As a seventh-grader, Sebastian was the only middle school student in a high school musical when he played the young version of the title character in The Who's Tommy before continuing to do theatre in high school. Like me, Sebastian is an avid cinephile, so we've never been at a loss for a topic of conversation. Recorded on 2/22/25.

When I first worked with Shelley Molad, she was part of an ensemble that sang Irving Berlin songs at retirement homes. Little did I know that her acting career would be so varied and include Chekov and true crime TV. This episode contains an unexpected cameo (audio) appearance by Shelley's children! Recorded on 1/19/25. 

As a sixth grader, Sam Strum was already a knowledgeable interpreter of the Broadway repertoire -- particularly the songs sung by kid characters. He had also already mastered the bell kick, which we took full advantage of overthe years. As we talked, Sam reminded me that he specialized in playing death scenes in shows we worked on. Recorded on 12/14/24.

I met Rich Zwelling through his brother (former student and former WAYN guest) Andrew. Rich and I immediately connected over our mutual appreciation for cinema, music, and education. This episode is a continuation of many of our conversations over the years. Recorded on 11/30/24.

In addition to lending his talent to Emery productions, both on and offstage, Jonathon Reckles was directly responsible for one of the most meaningful days of my life (7/8/2009). On this episode, we revisited that magical day and talked theatre and dry cleaning. Recorded on 12/7/25.  

Episode Notes:Charles Wayn's Web3 Evolution: From DLive's decentralized live streaming platform to the evolution into Galxe, a Web3 powerhouse, Charles shares his journey of innovation in crypto.Introducing Gravity: The launch of Gravity, a Layer 1 blockchain designed for high-performance and cross-chain functionality, is a game-changer. Charles explains how Gravity provides a scalable, decentralized solution for bridging multiple blockchain ecosystems with lower costs and higher speeds.Web3's New Era of Community Building: Learn how Galxe is reimagining the way Web3 communities grow, engage, and thrive. With a rewards platform that offers customizable quests and tokenized loyalty programs, Galxe is helping projects reach their full potential.AI Meets Blockchain: Charles talks about the integration of AI in crypto with tools like Alva, Galxe's AI copilot for crypto research, which empowers users and developers to explore, analyze, and optimize blockchain projects with real-time insights.Key Takeaways:06:45 - Gravity's cross-chain capabilities and how it simplifies decentralized applications' interactions across multiple blockchains.13:15 - Galxe's tokenized loyalty points system and how it can reshape reward structures for Web3 projects.21:00 - The seamless integration of AI with blockchain — why Alva could be the key to better crypto research and project management.28:30 - The broader implications of Gravity's high-performance Layer 1 blockchain on the future of Web3 infrastructure. Thank you for listening to The Charlie Shrem Show. For more free content and access to over 400 episodes, visit www.CharlieShrem.com.

I had the privilege of performing with Aaron Mark in productions of The Wizard of Oz and She Loves Me when he was a teenager. These days, Aaron is a renowned writer and director of stage, screen, and podcasts. He and I had a terrific talk about our Houston theatre experiences and his professional adventures on both coasts. Recorded on 10/25/24.

Ravintolaunelmia, ruokatrendejä ja natuviinejä. Vieraana yksi Helsingin kiinnostavimpia ravintoloitsijoita, The Wayn ja Maukku -ravintoloiden sekä Let me winen perustaja Toni Feri.  Puhutaan hyvän ravintolan menestysreseptistä, alan trendeistä, hyvästä asiakaspalvelusta sekä stadin ja maailman raflaskenestä. Rapid Fire -kierroksessa Tonin luottoresepti, lempiviini ja viimeinen ehtoollinen. Viikon parhaissa mm. bodari-Bellojen kuulumiset, Tampere-terkut ja uusi somesnack, jota on pakko päästä testaamaan.

David Blankfeld appeared in Emery's productions of Fiddler on the Roof, The Dining Room, The Who's Tommy, and The Mystery of Edwin Drood. Since high school, his creativity, drive, and passion extended to the world of video game development. Recorded on 10/19/24. 

While at Emery, Jonathan Endelman specialized in character roles in productions including Mame, Wonderful Town, A Midsummer Night's Dream. Over the years, he has impressed and entertained me with his prolific and detailed memory of his old high school theatre days and inspiring tales of the world travels his career has taken him on since then. Recorded on 10/13/24.

In 2012, at age 50, I enrolled at Columbia College Chicago. While there, I forged lasting friendships with a handful of my much younger classmates, including this week's guest, Colin Fagan. I really enjoyed discussing how our very different age demographics affected our shared college experience. Recorded on 10/6/24.

When Stephen Abrams did shows during his middle and high school years, I was struck by how his calm and quiet everyday persona resonated onstage. During our discussion, I learned that Stephen's post high school experience was anything but calm. Therefore, I feel this episode requires a serious footnote. I'm extremely grateful that Stephen felt comfortable enough to be so open and forthcoming with his story and for approving the edit. However, what he shared took our visit to dire places that may not be suitable to more sensitive listeners. Recorded on 10/5/24.

Blake Nolingberg and I met when he was eight. Outside of theatre classes, I was the Children's Chorus Supervisor when Blake performed in TUTS productions of Cinderella and Jesus Christ Superstar. In addition to recalling backstage stories and getting caught up on his current life, Blake and I discussed our longtime mutual affinity for vintage TV reruns. (When we worked with Ruth Buzzi, he was the only kid in the cast who knew who she was!) Recorded on 9/29/24.  

For a change of pace, this week's guest is friend and former teaching colleague, Rozanne Curtis, whom I first met when we were both in the cast of a production The Wizard of Oz. We had fun sharing our adventures as longtime Theatre Arts educators. Recorded on 9/28/24.

When David Waghalter was a teenager and I was barely an adult, we appeared together in productions of Peter Pan and The Wizard of Oz. In fact, for a number of years, I worked on shows with David's entire family! Join us as we recall stories from onstage, behind-the-scenes, and a very strange housewarming. I also learned what David's been up to since the 80s! Recorded on 9/15/24.

Since I've started this podcast, many listeners have commented on how much they enjoy the theme music. This week's guest, Joshua Rosner, composed and performed the song, titled “One for Barbara.” We share the song's back story, recall EWS productions of Fiddler on the Roof and How to Succeed in Business…, and learn what Joshua is up to these days. Recorded on 8/31/24.

Perhaps by coincidence, several of my strangest theatrical experiences were alongside Kevin Arsham, starting with our lip-syncing to a Chipmunks cover of Blondie's “Call Me” in a children's revue called Pure Imagination. Kevin and I reminisced about this and other odd onstage adventures and caught up on his post-theatre life. Recorded on 8/25/24.

I first encountered Carlie Dorshaw Moe at Theatre Under the Stars when she was eight. We later worked together at I. Weiner Middle School and the JCC Summer Theatre program where she both performed and acted as a theatre camp counselor.  I last worked with Carlie in 1999. It was great finding out what she's been up to in this century! Recorded on 8/24/24.

Stephen Uzick holds the distinction of being the first (of several) of my students to later be taught by my sister, Maxine Goodman, at South Texas College of Law. Prior to that, Stephen was a fixture of the EWS Theatre Department, both onstage and behind the scenes. Recorded on 8/10/24.

In middle school, Adam Siegman was a star on both the stage and the basketball court. He and I talked about how he uses the experience he gained working before an audience in his current work. He also regaled me with the most astonishing on-the-job training story I've ever heard! Recorded on 8/10/24.  

Elliot Levy appeared in our production of Joseph and the Amazing Technicolor Dreamcoat. We discuss that and how, decades later, he and I wound up as fellow University of Chicago students. Also, two weeks after this interview was recorded, Elliot and his wife welcomed a baby! Mazel tov! Recorded on 8/5/24.

As an eighth grader, Michael Abrams appeared in our production of Hello, Dolly! as part of a cast of 112 middle schoolers. In addition to recalling the experience and filling us in on journey to his current life, Michael took some time to pay tribute to his mother, Rabbi Judith Abrams's memory. I was grateful for the opportunity to recall Rabbi Abrams's profound contributions to our production of Fiddler on the Roof. Recorded on 8/4/24.  

This week, I'm pausing from the usual WAYN routine to pay loving tribute to the following students/friends who are no longer with us but remain present in my memory and heart: Mike Barrett, Karen Bull, Miriam Goldman, Nicole Hurst, Paul Hussman, Ryan Maidenberg, Ryan Mendeloff, Jeff Nathan, Kevin Penn, Greg Potylchansky, Shalonda Price, Leslie Robins, Daniel Rosen. Zak Rosen, AlexSacks, Adam Shney, Jeremy Tucker, Scott Wilson, and Harris Wittels.

I had the privilege of directing Miriam Cantor-Stone in productions throughout their middle and high school years. During our visit, I was thrilled to discover that the quietly enthusiastic theatre kid whose ability to deliver even the corniest lines with stunning sincerity is still delivering “performances” of a kind. I loved hearing about their refreshingly unorthodox and fulfilling life path leading to this point. Recorded on 8/3/24.

When I was Carlos Miranda's English teacher, he was one of only five 7th graders at Banff Private School where he also performed in numerous productions. Since then, his schooling and career have taken him around the world. Carlos and I discuss his post-middle school adventures, how he met his wife (a best-selling author), his surprising celebrity encounter during the intermission for Batman Live and, of course, movies. Recorded on 7/31/24.

I first met Kevin Richie when he was three and I acted in shows with his father. A few years later, I played Kevin's father in an original musical called America. Kevin was the first of several young actors I worked with who showed an early flair and appreciation for technical theatre (a blessing for me because I have zero talent in that area). Kevin went on to mentor Blake Minor (last week's guest) and their careers continue to intersect on occasion. Recorded on 7/30/24.

I first worked with Blake Minor when he was a 7th grader and he did double duty as both actor and lighting technician for Anything Goes. Since then, Blake has dedicated his career to Technical Theatre Education. We had a terrific talk about, among other things, how Technical Theatre and Arts Education have changed since our time at Welch Middle School. Recorded on 7/29/24.

Ryan Surles was eighteen when he took classes at Theatre Under the Stars. The following summer (1989), I recruited him to play Bud Frump in my directorial debut, a teen production of How to Succeed in Business Without Really Trying. Years later, when my niece was a toddler, Ryan was her teacher at Gymboree. A former Las Vegas resident, Ryan gave me a piece of sage advice before I moved here. These and other random connections are discussed within. Recorded on 7/26/24.      

Congratulations to Taylor Shepherd! Taylor holds the distinction of being my first former student (that I'm aware of) to become a grandparent! (His granddaughter arrived a few weeks after we recorded this interview.) We discuss his performing in Oliver! as a 7th grader, his travels since then, and what he's up to nowadays. Recorded on 7/24/24.

Tina Melamed Jaremko and Tanya Robinson are identical twins but when I was their camp counselor and middle school theatre director, I never had any trouble telling them apart. It was great to hear their mutual memories and learn about their notably individual (though sometimes oddly intertwined) journeys to where they are today.

Jake and I met at the JCC Performing Arts Summer Camp when he was eight and we immediately bonded over our mutual appreciation for a certain movie. Never satisfied to fill his time according to someone else's rules, Jake has forged a singular life path for himself, including an unusual "side hustle" that really took off!

In the summer of 1989, I directed my very first production and Sarah Guzick was in the cast. That experience would turn out to be formative for both of us, for different reasons. Through our conversation, I learned about the joys and tough realities of the journey that Sarah's love of theatre took her on.

I worked with Jer Moran for only two weeks at the JCC Performing Arts Camp, but decades later, we reconnected in Chicago. Now, Jer lives in Austin, creates intriguing theatrical and cinematic projects, and tends to a collection of rather unorthodox house pets.

When I worked with Roxie Maisel on middle school shows (in 1999 and 2000), she proved that she wasn't afraid to take creative risks onstage. Twenty-five years later, Roxie's adventurous spirit and drive are still very much intact as she shares details about her current life in New York!

This big crock of clickbait is STREAMING babe! Josh met a new nipple-surgeried brother, Ben has the secret sauce for losing the L-Bs, Ben's dad drives SLOW, Josh's mom fell (she's OK), and everyone loves GAY CLUBS! Let's do it all: best bite of the week, speakpipes, WAYN and more! Enjoy! What are ya nuts?!Leave us a voicemail here!Sponsors:DrinkAG1.com/goodguys for a free 1 year supply of vitamin D and 5 free travel packsHero Bread is offering a special 10% off your first order on their new recipe with the code GOODGUYS24 at Hero.coSignos.com code GOODGUYS for 20% off select plansPlease note that this episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Merriam-Webster's Word of the Day for May 15, 2024 is: wane • WAYN • verb To wane is to become smaller or less, or in other words, to decrease in size, extent, or degree. // The national scandal caused her popularity to wane. See the entry > Examples: “In 2023, Royal Caribbean's bookings hit an all-time high ahead of the launch of its newest ship, the Icon of the Seas. Interest has yet to wane: The three strongest booking weeks in the company's history were at the start of 2024 and ‘wave season,' when cruise lines typically roll out flashy discounts to incentivize reservations.” — Brittany Chang, Business Insider, 20 Mar. 2024 Did you know? In her book Braiding Sweetgrass, scientist Robin Wall Kimmerer, an enrolled member of the Citizen Potawatomi Nation, recounts some of the stories of her people surrounding Windigos, fearsome, shrieking monsters that prey on human flesh: “The Windigo is most powerful in the Hungry Times. With the warm breezes his power wanes.” Wane is a verb used when something—such as strength, power, or influence—decreases or diminishes, usually with the implication that the lessening is gradual, natural, or—as in the case of the Windigo—seasonal. Daylight wanes, as does summer. In a classroom, one's attention may be said to wane if, minute by minute, one becomes more interested in watching birds through the window than following the points of the professor's lecture. For centuries, wane has also been called upon to describe the seeming decrease in the size of the moon in the later phases of the lunar cycle. The traditional opposite of wane is wax, a once common but now rare synonym of grow. Wane and wax have been partnered in references to the moon since the Middle Ages.

Support the show

In our latest episode, join me as I sit down with Charles Wayn, the dynamic Co-founder and CEO of Galxe. As a pioneering platform in the web3 ecosystem, Galxe has achieved significant milestones: amassing over 10 million users, integration with 16 blockchains, and enhancing the growth of platforms like Optimism, Polygon, and Arbitrum. The heart of Galxe's mission? Helping more than 2,000 partners craft reward-based loyalty programs that resonate with their genuine fans. During our conversation: Charles spills the beans on the secrets behind Galxe's meteoric rise, with nearly a million followers on Twitter and an impressive clientele of over 3,000 businesses. Get insights on strategies that work in both Bull and Bear markets, essential knowledge for anyone navigating the ever-changing landscape of web3. Discover the future's lucrative opportunities as foreseen by a leader in the space. If the idea of community-driven growth sparks your interest, or you're just eager to gain knowledge about the world of web3, then this episode is a treasure trove of insights. Dive in, and let's explore the realm of community engagement in web3 together! Nothing mentioned in this podcast is investment advice and please do your own research. Finally, I don't run ads on my podcast. It would mean a lot if you can leave a review of this podcast on ApplePodcasts or share this podcast with a friend. Connect with Charles and Galxe here. https://galxe.com/ https://www.linkedin.com/in/charleswayn/  Connect with me here - https://twitter.com/samkamani or https://www.linkedin.com/in/samkamani/  --- Send in a voice message: https://podcasters.spotify.com/pod/show/web3podcast/message

OPJ NFT Link: https://overpricedjpegs.cc/buy-opj-nft   OPENSEA | DROPS Check out the latest drops in OpenSea: https://overpricedjpegs.cc/OpenSea  GALXE | MINT LIST Check out all that Galxe has to offer at: https://overpricedjpegs.cc/galxe.  WEB3SENSE | DEMO Find out more + get a demo today: https://overpricedjpegs.cc/web3sense 

OPJ NFT Link: https://overpricedjpegs.cc/buy-opj-nft   OPENSEA | DROPS Check out the latest drops in OpenSea: https://overpricedjpegs.cc/OpenSea  GALXE | MINT LIST Check out all that Galxe has to offer at: https://overpricedjpegs.cc/galxe.  WEB3SENSE | DEMO Find out more + get a demo today: https://overpricedjpegs.cc/web3sense 

We're talking to Pete Ward, the Co-Founder and CEO of Humanity. Until now, the thought of slowing or even reversing the ageing process has been pure science fiction. But using readily available technology, Humanity are out to change that.  As a society, we've fallen prey to the idea that there's a one size-fits-all methodology that will improve people's health -exercise more, eat healthier, drink less - you've heard it all before. But Humanity, have recognised that everyone is built differently. By using their app to track your nutrition, movement and mind, Humanity say you can compare yourself against the global datasets, revealing what you, specifically, should do to improve your personal health. Before Humanity, Pete had several successes behind him.One of his earliest was WAYN.com, which he also Co-Founded. They were the largest social travel network for over 13 years before he sold it to to lastminute.com in 2016. And now, with Humanity, he wants to have a more meaningful impact on the world.  Pete's story is fascinating, and he's got advice on mentorships, why you probably have more leverage than you realise and how you should always think twice before giving up in the face of adversity.  You can't change your chronological age, but can you really change your biological one? Listen to find out. --------------- We'd love your feedback hello@secretleaders.com --------------- Sponsor links: evelyn.com/secretleaders/ vorboss.com/secretleaders personio.com/secretleaders vanta.com/secretleaders

Feysal Salat waa madaxa Jaaliyada Soomaalida Queensland oo qabanaya xaflad wayn oo lagu xusayo 1 Luuliyo.

Dawlada federalka Australia ayaa markii sadexaad baarlamaanka horgaysay hindise sharciyeed lagu xoojinayo awooda dawladu ay u leedahay inay tarxiili karto dadka lagu helo danbiyo waaweyn.

Qof wayn ani iima tihid

Kiribto Somali tv waa Goob Aad ka Baran Karto lacagaha dhijitaalka Ah iyo Tech, yada Blockchain cryptocurrency AfSomali ah waxaad kaloo nagala socan kartaa shabakada kiribto.com ama barteene youtubka www.youtube.com/c/KiribtoSomaliTv?sub_confirmation=1 isticmaal browserka amaanka ah ee xawaarihiisu sareeyo ee brave browser kala soo dag halkan brave.com/?ref=kir251 mahadsanid

懶惰人IG粉專:https://www.instagram.com/lazypal35/?hl=zh-tw 你也想讓自己的幹事分享給廣大的聽眾嗎？ 歡迎點擊連結投稿至幹事信箱！ 本集重點: Allen肌肉拉傷了 勃起收了一整套進擊的巨人漫畫 懶新聞開放募資 強尼寶寶好棒喝醉打給前男友狂罵 喝醉酒通常都是無意識的發酒瘋 Allen是同志天菜嗎 三寶終結者送醫院清潔阿姨回醫院 Allen是中和三寶終結者 三寶跟性別的相關性 前面放狗狗就可以當三寶 想搭訕女生直接開撞 三寶終結者偷說學長壞話 高中吉他社學弟的奴性 台中懶新聞投稿王不小心看到爸爸的雞雞 Allen和哥哥暢聊爸爸的雞雞 台中懶新聞投稿王63.6度燒壞腦袋 Taco抄作業害別人0分 偶像劇女主角目擊阿伯在路邊尻尻 隔著褲子尻尻有犯法嗎 高雄自衛隊Wayn抓了陌生人的胸部 安哥也練就了一雙無影手 Allen國小就偷摸女生胸部 男生為什麼要互打老二 SKT FAKER雞巴老闆偷吃員工的薯條 嘉義雞肉飯小時候的蟑螂危機 用泡泡殺蟑螂是娘泡 勃起全身防護罩殺蟑螂 Allen被蟑螂噩夢嚇醒 大家要將心比心對待蟑螂 Apple Podcast評論環節 勃起推薦音樂:嘴哥樂團-同類

Michael Geer is co-founder and CSO (Chief Strategy Officer) of Humanity Health, a London-based startup that's building an iPhone app and subscription service designed to help users slow or reverse their rate of aging. Geer's co-founder Pete Ward has described the app as like “Waze for maximizing health span," or years of healthy functioning. The Humanity iPhone app, which is currently being beta-tested by users in the UK, is designed to track various types of health-related data for free, such as exercise levels. At various premium subscription levels users will be able to track biomarkers in their blood samples and even track the levels of methylation in their DNA. The app’s machine learning algorithms pull together all of this data to produce what the company calls an “H Score.” The big idea is to show well users are doing at slowing their aging—compared to others who have similar profiles or have taken similar actions—and to advise users on what else they could be doing to increase their H Score and their health span.Harry interviews Geer about the startup's origin story, the app's features, Humanity Health's business model, and the argument for better integration of clinical and digital data into consumers' everyday health decisions.You can find more details about this episode, as well as the entire run of MoneyBall Medicine's 50+ episodes, at https://glorikian.com/moneyball-medicine-podcast/Please rate and review MoneyBall Medicine on Apple Podcasts! Here's how to do that from an iPhone, iPad, or iPod touch:• Launch the “Podcasts” app on your device. If you can’t find this app, swipe all the way to the left on your home screen until you’re on the Search page. Tap the search field at the top and type in “Podcasts.” Apple’s Podcasts app should show up in the search results.• Tap the Podcasts app icon, and after it opens, tap the Search field at the top, or the little magnifying glass icon in the lower right corner.• Type MoneyBall Medicine into the search field and press the Search button.• In the search results, click on the MoneyBall Medicine logo.• On the next page, scroll down until you see the Ratings & Reviews section. Below that, you’ll see five purple stars.• Tap the stars to rate the show.• Scroll down a little farther. You’ll see a purple link saying “Write a Review.”• On the next screen, you’ll see the stars again. You can tap them to leave a rating if you haven’t already.• In the Title field, type a summary for your review.• In the Review field, type your review.• When you’re finished, click Send.• That’s it, you’re done. Thanks!TRANSCRIPTHarry Glorikian: On Star Trek the Vulcans have a saying: Live long and prosper. The “AND prosper” part is important, because nobody wants to live a long life, if it comes at the expense of their health and prosperity.In fact, there’s a growing notion in the healthcare industry what you should really be trying to optimize isn’t your lifespan but your “healthspan,” meaning, the number of years of healthy functioning you can look forward to. And that’s the main idea behind a new smartphone app and subscription service being developed by startup based in London called Humanity Health. The company came out of stealth mode in the UK last fall.  It’s testing its iPhone app on beta users in the UK now and will soon open up to users in the US.The way Humanity’s CEO and co-founder Michael Geer explains it, we can’t affect our chronological age, but we can affect our biological age, if we take the right steps to stay fit and prevent disease. The Humanity app is designed to track various types of health-related data for free, such as exercise levels. At various premium subscription levels users will be able to track biomarkers in their blood samples and even track the levels of methylation in their DNA.The app’s machine learning algorithms pull together all of this data to produce what the company calls an “H Score.” The big idea is to show well users are doing at slowing their aging, compared to others who have similar profiles or have taken similar actions, and to advise users on what else they could be doing to increase their H Score and their healthspan.It’s intriguing stuff. But the jury is still out on whether Geer and his colleagues can scale up a premium health-tech service to millions of customers. That’s one of the questions I covered in my interview with Geer, which we’ll go to right now.Harry Glorikian: Michael, welcome to the show.Michael Geer: Thanks, Harry. Yeah, excited to be on here.Harry Glorikian: So. Let's start off like I mean, before we get into the details on the company or what you're doing there at Humanity is, you know, your background is more tech than it is health. So what did you do in the past and what sort of prepared you for starting a health tech company?Michael Geer: Yeah, for sure. Yeah, so I guess I started off as a failed astronaut, I did aerospace and space. I'll get there eventually, pay my way in as many of us will end up doing. But yes, then because of that obsession, ended up over in Moscow and ended up starting one of the, you know, being on the founding team of one of the biggest dating sites in the world, Badoo. When I left Badoo, which is around 2010, I it was those two years right after that that I had a couple of people close to me got late stage cancer.Michael Geer: And so sitting there in my late 20s feeling invincible, as you do in your late 20s, and you had this success but couldn't do anything for these two people, felt completely helpless. And so what I guess started searching for at that point was, it started with a specific journey, which was, OK, why are people finding out, you know, late stage about cancer like these? These were two people that were living in cities, they're middle class. There was no reason why they didn't have access to medicine or health care. And they were still, you know, finding out stage four in both cases. And so I started going down that rabbit hole. And I guess my engineering background is probably what has led me through my life, whatever, you know, job or business I started. And so just like, OK, why aren't we why aren't we screening everybody for cancer? Then the next step was, you know, the main answer was too many false positives in the tests that we screened. Everybody will send people towards a bunch of procedures. They don't need to kill more people than we save kind of thing.Michael Geer: And so I had reached out to, being a founder, you start just you know, if you want to learn about something, you just reach out to the top person in that space. I reached out to George Church, he was actually the first person that I asked about genetics. Yeah, he was kind enough to meet with me, answer all my stupid questions. And so it went. I wasn't planning to start a health tech company. This was more personal, like I need to learn more about this because I don't want to feel so helpless, because unfortunately, I think this will probably happen, continue to happen. And just on a personal note, my uncle just passed away from cancer a couple of days ago. So it continues to happen.Harry Glorikian: Sorry.Michael Geer: Thank you. But I think there is a difference between then and now, as I do have a lot more optimism, because, you know, there's things like, you know, Grail and companies like that that are really kind of pushing the envelope on early detection. But anyway, getting back to your question, so when I started to believe that we could actually start a company in the space and get into health tech was when I was in so many rooms with all these great scientists, these stem cell researchers, immunologists, people out in the Valley when I moved out there, and they ... you know, there's so many breakthroughs that happen in science and so much known knowns that you're sitting around in these rooms with the scientists and they're like, yeah, of course, that's the way it is. And you're like, OK, tell me more. And you can see that they've done the experiments. They have the data. It shows that that's the way it is. It's just these aren't the same people that know how to get to a million people. You know, the distribution path is quite simple on that side, is you need to get it to a pharma company or something like that, then they have the way to get it to all the doctors and then the doctors can distribute it to people.Michael Geer: And so what I started to see in the preventive space, and that's when I dragged in Pete, my co-founder, which we can talk more about, was that there was just a ton of stuff that we already knew in science that we could actually bring out to people on the preventive side, both monitoring their health and also directing them and, you know, guiding them and what they can do, that there needed to be more people on the consumer tech side actually bringing that out to the millions of people through that distribution path, because really the pharma-doctor path doesn't actually work as well or really at all right now for preventive measures.Harry Glorikian: Well, it's that, you know, that whole system is not necessarily designed for paying for prevention, it's paying for, you know, fixing something that's wrong.Michael Geer: Yeah, I mean, it's that I mean, that's definitely that probably the top one. It's also, it's just the system of indications. And then when you have an indication, then you can market to it, like the whole distribution pattern is based on, you need to have a very finite target. And preventive stuff isn't as finite.Harry Glorikian: Yeah, yeah. I mean, there are some things that we can clearly, you know, we know what the marker is and we can see the disease that it causes. So you try to get ahead of it. But some of the areas that you guys are looking at, you know, is still, I want to say a work in progress, you know, there's no, say, defined marker for aging, per se, right, that I know of. What convinced Peter to join, because I think he was someone he was somewhere else, right?Michael Geer: Yeah, so and then we should go back to the markers for aging because this is a fun conversation I always have with folks. Yeah. Yeah. So with Peter, he was similar. He didn't want to be an astronaut. He wanted to be an entrepreneur his whole life. So he succeeded and in his very first love. But he was at the beginning of the social networking boom, had an amazing website that called WAYN. It basically allowed you to connect with people around the world, which we kind of take for granted now. And so he had gone on that path and was just, you know, we had met each other in London, had really respected each other. I had actually jumped on and worked with him at WAYN for a couple of years, for a few months. And so we figured out we could, you know, work well together. And so really, he was I would like to say that he was the top of my list. I think he was my list when I wanted to found something new. It was it was like, no, I need I need Pete to come in on this with me. And, you know, we have the same consumer tech side, but he has just a lot of skills with team building and, you know, investment and stuff. That's just that's not my usual daily focus. So it makes for a good team. And but it was also important that he believed me and believed in the science. And so that was that was kind of that first process. We actually went on a bunch of what we called at the time, like science fantasy camps. One of them was, Illumina has a program called, or they did, I'm not sure if they still do, "Understand Your Genome."Harry Glorikian: Yep. I've done it.Michael Geer: And so we went to this one was in Boston. And so it was like we went there. We actually I think we generally picked up a couple of our future science advisors and that one trip alone. And so, yeah. So after, and again, it's this kind of process and that's what we hope humanity will be able to do in a faster process, is get that message out that there is a difference in the rates that we age and that our bodies lose function and we can do something about it. And I think those kind of two years of traveling around on and off with Pete was kind of the very hands on version of what we hope to do at a bigger scale with Humanity. And so once he came around and became a believer like me completely, then then we started looking at what we could actually build.Michael Geer: So tell me, what is Humanity, the company offering to people? What is the, call it the product, or the subscription? Right. Walk me through what it is. And maybe at some point you can sort of also go through what the app is, that sort of pulls all this together so that the person can see their information.Michael Geer: Yep. Yeah. So our main focus with Humanity is to extend people's health span, which basically means, you know, increase your, as much as possible, healthy years. So wherever you're starting from, just keep you either at that level or make you healthier and make sure that that continues as long as possible. Health span, probably a quick way for people to think of it, and biological age, we can get deeper into that, is the idea that, you know, you can have a very unhealthy, you know, 75-year-old or you can have a really healthy, you know, fairly fully functional 75-year-old. And so you want to be that fully functional 75-year-old. And the same thing for the 40-year-old and the 50-year-old. And so our focus is basically to allow people to start to see what actions they can take on a daily basis to basically extend their health span. So basically, we put it in the app as you know, reducing your biological age, which is just a measure of your kind of probability of disease and a measure of your current function of your body. And so the idea is to have all that working in the background, the collection of all that data, the running it through the predictive models, but really to the user just nudges and kind of information that guides them towards doing more the actions on a daily basis that they need to do to, you know, increase their health span.Harry Glorikian: So how does that differ from, say, I mean, you know, there are all these other, there's obviously the Apple Watch, right, get up, walk around, breathe, all that good stuff. Then there's things like the WHOOP band, which, you know, sort of gives you things like stress scores. And, you know, supposedly you could be able to tell whether you had alcohol the night before or not because it, you know, disrupts sleep patterns. And so how does what you guys are putting together, you know, make a difference? I mean, I remember seeing something about taking blood regularly. What are the components that you guys have put together to sort of build a full package?Michael Geer: Yeah, I think, and what we saw in the space, the questions that Pete and I started asking when we were kind of submerging ourselves in the science, was, OK once we fully believed in this idea that people age at different rates, there's a thing called a biological age, which is just kind of a coined term of describing that loss of function. Then we started asking very product kind of consumer tech questions like, OK, first of all, can we measure it? And second, very importantly, can we measure it for a low enough price that we could actually bring this to direct to consumer? Because, I mean, we talk about this kind of off camera. But one of the reasons we know each other here is because through Christine, who runs Evidation Health and I for years would always be tagging along to different conferences when I was running the tech companies. And seeing people go through this trouble in those first years. And what me and Christine saw kind of falling by the wayside is all these very motivated people who come into the space. And the next thing you know, all they could talk about is we're trying to get this deal with this insurance company. That was kind of like the never-ending kind of cycle of optimism and then kind of loss of optimism.Michael Geer: And so we basically started with, OK, can we measure it and can we do it cheaply enough? And so then we basically, I guess and the reason, the fact that we started at that basic kind of science level, I think, is different than a lot of people started. So like Fitbit would start with, can we measure this particular action, right. Or WHOOP would start with, you know, can we can we help athletes know how much they've recovered and how much with exercise the next day. We started much more on the side of, can we just measure people's function and loss of function in their body and then evolve from once we figured that we could do that and cheaply enough, the idea evolved to, OK, once we do that really well, we just give this feedback loop of are you know, are you becoming younger or are you becoming older in the loss of function since then, we could also monitor all the actions that we're taking and start to basically change the weightings of the points that they're getting from those actions and start to actually guide people towards changing this first main thing, which is, you know, is their biological age going up or down?Harry Glorikian: So when you're doing one of these blood tests, what are you measuring in a blood test? Right. I could show you the laundry list of stuff that my doctor orders for me. Right. Which, you know, if you don't know what they are, it's basically gobbledygook. But just curious.Michael Geer: Yeah. And I think that's, I mean, we try to stay out of the weeds presenting this to the user base, but I think talking to investors and talking to other people in the space, the inside baseball on this is, this overconcentration on like moving one marker? It's kind of also based on what we started with, talking about clinical trials. Clinical trials and those kind of research studies are based on trying to see if one thing affects this other thing. And so you end up with this kind of conglomeration of, you know, cholesterol is bad for you. So whenever we see cholesterol outside of the norm, then we just need to concentrate on getting that one marker down. But I think most people have kind of, most doctors, and I think definitely all scientists now, have come to the understanding that all these things are kind of homeostasis of, and representative of, homeostasis in the body. And so you can't just concentrate on one marker moved one way or the other. That's one thing. So, OK, great. Mike, you know, don't look at one marker. So you look at all the markers. Yeah.Michael Geer: So what you end up doing is you need to have a longitudinal data set which has future health outcomes. So, basically that you can see the future. Right. And so, you know, and so the examples of this is like UK Biobank, Estonian Biobank, Framingham in Massachusetts, you got Jackson Heart Study. And so, you know, the future health outcomes. And then luckily, in many cases, you have past markers that have biomarkers that have been taken. And this, you know, example, the clinical markers, the analytes in the blood. And so really what ends up happening at this point, although one of our SABs has kind of taken this to the next level, is a lot of times you end up with the common panels. So your lipid panel, your full blood count, that sort of stuff, you end up with, those are the markers that you want to grab, because those are markers you can compare to that longitudinal data that has the health outcomes. So you can do your models. Kristen Fortney, just give a shout out to one of our SABs, has a company BioAge. She took it to the next level because a lot of these bio banks actually have stored samples. And so she would take the samples off the shelf and measure a lot more analytes. The reason why the first part is actually very useful is those analytes end up being very cheap and the same thing.Harry Glorikian: Right.Michael Geer: So you kind of actually want to keep on that level. You want to you want to say, hey, I want that $5 panel, that $8 panel and put them together. And then that's going to give me a predictive model. And so if I can get to that point, which we can, then that's better than, you know, the $1,000.Harry Glorikian: No, no. I mean, but, you know, like I was talking to Joel Dudley from Tempus and they're trying to basically off of one sample, do every, you know, thing you can do on it and storing that because they know that over time like that, data set is going to have more and more value that that will be created. Right. So it's sort of what do I do today versus what should I be doing to get ready for tomorrow?Michael Geer: So there's two things there. And, you know, there's great people like Mike Snyder out at Stanford in the precision medicine kind of personalized medicine space. Right. And the stuff that they're doing is super valuable. They're basically, yeah, they're getting every marker on everything and they're like highly phenotyping, as they say, kind of people. The thing is, when you do then go to bring that to the masses, you do need to go through a process of basically whittling it down to what are the markers we can actually collect at any time, because that that kind of limits your ability to actually bring the service to a user. Right.Harry Glorikian: So there's a basic subscription and then I think a premium subscription. I mean, there's, trying to figure it out from reading a bunch of stuff which isn't clear, necessarily clear on the website.Michael Geer: Coming out of stealth, we're still in closed beta. So, yeah, we're still a little bit stealthy.Harry Glorikian: So what's going to be the offering and what is somebody's get for what? I guess.Michael Geer: Yeah. So I mean, like anything, these things will iterate. But right now, so we brought in 70 alpha users, fully paid alpha users in the UK, which is not actually traditional. Usually you bring in people for free. But we wanted to see if people were willing to pay different prices to get the service. Harry Glorikian: I want to pause the interview right here because just as Michael was explaining the company’s pricing model, out Internet connection dropped. I followed up with him later and got the details by email.Michael explained that the company is currently testing different price points for its different subscription levels with its test customers in the UK.  Some of the tracking features will be available for free. For an entry-level subscription fee, customers will get insight into their biological age and what actions are working for people like them. The company is currently testing a price of around $30 per year. And one level up from that, customers will be able to send in blood samples for clinical tests of common biomarkers like lipid levels, for a fee of around $100 per quarter. And for an even higher fee of around $300 per quarter, the company will analyze customers’ DNA methylation, which is thought to be one indicator of aging.Michael wrote to me, quote, “Pete and I have built freemium applications with millions of subscribers in multiple past projects and really love its ability to deliver more good to more people globally,” unquote. Okay, back to the interview.Michael Geer: And the accuracy, you know, as you combine those models becomes higher and higher. Our goal, though, is definitely to make the digital side as predictive as possible, which I think I mean, we can either get into it or not. But the frequency of measurements, you know, all this kind of stuff plays into how predictive a model can be and obviously your data set with the future outcomes. And so we think there's no kind of mathematical or science reason why the digital biomarkers can't be highly predictive.Harry Glorikian: Well, I mean, there's always stuff you can't see that's inside. Right. That's happening at a different level. I mean, if you look at all the work that's happening with, you know, the Oura ring or now that, you know, there was something on the Apple Watch. Seeing certain physiological changes ahead of time, you can sort of predict what's going to happen. If you could actually, like you said, Grail and you know, some of the other companies out there like Garden, they're looking at blood where you can see, you know, very small changes that might predict some future state. But, so look....Michael Geer: On that point, I think the future is definitely, ... From consumer tech, it's all funnels. And so my mind is always thinking funnels, you know, but in the medical space, you would call it triaging or, you know. So I think the future is definitely that you start off with a digital, you detect something. It might not be clear exactly what it is. You then you then get bumped up to your GP or your you know, your family doctor or, you know, you go through kind of a telemedicine, go through PWN into your Grail test, if they think that that's like the next step. All that's built out. And honestly, I think you're 2021 is going to be quite a year for, like, all that stuff to finally come to fruition at least in its first kind of prototype form of that that whole funnel of health that make sure that we're much more protected than we are.Harry Glorikian: Yeah. I mean look, so, you know, we can both agree that the medical establishment, which, you know, I have a, I'm trying to have my feet in both spaces because they're colliding, as you know, definitely would say, look, if you're more active, it's you know, you're going to be healthier than when you're less active. Right. Couch potato versus somebody that at least goes for a walk eating unprocessed foods, right, is healthier than eating a lot of, like, snacks. Funny, because my son said to me, oh, my God, I hate so many Cheetos last night. I feel like I have a rock in my... So clearly not a good thing to do. Right. Meditation can reduce stress. I keep trying to impress on them that they should pick this up as a habit. Not when you're older, like I am. Right. And that decent sleep every day makes a huge difference, because of recovery and so forth. I'm sure the medical establishment would say, like, look, if you can track these things and make yourself better, that's probably good. And then, OK, if you can look at bloodwork and DNA genotyping and methylation, even better. Right. Which is Ventner's old company, Longevity, was is a company that's trying to do a lot of that stuff. What is Humanity adding to this equation? What is the argument that distills all this data down to what you're calling, I believe it's an H Score.Michael Geer: Yep, yep. So the. So there's kind of two things missing at the moment, and they exist in different pieces, in different places. The first is on the holistic actual connecting your biomarkers with these longitudinal data sets that have the future health outcomes. Like the real predictive. So it's it sounds a little inside baseball, but a lot of these systems are actually built on a different paradigm. And a lot of the systems are actually built on a bunch of cobbled together meta-studies of clinical trials. Which, as people that kind of focus on the on the space, you know, everything goes to zero. It's like a statics course. It's like everything kind of just evens out. And so a lot of the stuff is based on kind of picking and choosing which kind of meta studies you believe in, which then dictates what means you're being healthier and what means you're not. And so the thing that me and Pete wanted to make sure is that this thing is really built on real data because you could just as easily, you know, just say, OK, what do you what are you doing? OK, here is the US or WHO or some organization says that this is healthy. So this is what this is what your score is going to be. But we have the data. So why don't we actually be sure about it and actually build it on these models? So that's one piece. Michael Geer: The Humanity Score is the ability for giving points based on we're seeing those actions actually play out in that biological age. And so, again, it's not this is not this based on what people recommend generally, because as you well know, like as we grew up over the years, you know, recommendations have changed wildly. So and that's not to say that they weren't based on the best kind of knowledge at the time. You know, maybe, sometimes not. But so the recommendations shouldn't be the basis of knowing what actions I should take. But the last piece of that is, like all of us are different. And I think everybody, all doctors and definitely scientists can agree on that. And so being able to actually say this action and these combination of actions, that's the important part. The combination of actions. The Humanity Score allows us to dynamically, you know, change the score based on what we see in your biological age result. And so I'll give you one example. This is an example. So if you didn't sleep very well last night and you ate badly the day before 2:00 and then you got up early and you went for a 5K run, what you over time, what you see and a lot of these kind of longitudinal data is that you're actually being less healthy going out for that 5K run. You're actually, you're stressing your body too far. And I mean, this is the you know, this is what it seems the data saying. And so you can't just single out actions and just say, hey, you should run more. Hey, you should do this more, because the combination of those actions is very vital to whether it's healthy or not, so that the Humanity Score allows us to kind of put all those together to help them know if they're heading in the right direction. And so a single score that pulls together all these things to give you. One anecdote also is a lot of the people that we see now coming into the app or a bunch of them, if they're very healthy, a lot of times for some of them, that means the high intensity training like, you know, five mornings a week. But these same people then go to their desk and they sit there without moving for the next the next eight hours. Right.Harry Glorikian: That would be me. That would definitely be me.Michael Geer: Some people, maybe my co-founders. And so what's and but we know this constant touchstone where you can basically see what is the next action I can do to increase my score. And then you have this one score. It just is much better from a user motivation side than if you go into, I won't name any particular company, but if you go into their app and you need to go to your chart and you need to go to your steps chart and you need to go to that, it's like great, a lot of data, but it's not really guiding me in the direction I need to go.Harry Glorikian: Yeah, I mean, there's a couple of companies, right, that have tried to come up with this sort of aggregated score. It's funny because I know some of these and I know like couples, literally husband and wife will be almost competing on which score was better. Right. So let's you know, we're talking about an awful lot of data coming from a lot of different sources. And so what do you guys, how does machine learning play a role here? You know, what are you guys doing in a sense? And, you know, when I talk about A.I., I think it's just like, OK, here's my toolbox and I've got all these tools. And depending on what I'm trying to fix or what I'm trying to work on, I'm going to pull out this wrench or a hammer, I think. But it's part of the same toolbox. So how are you guys approaching this? Of course, without giving away the secret sauce of what are you guys doing? What patterns do you hope to detect and what predictions are you hoping to provide for users?Michael Geer: Yeah, I mean, our aim is really on the one side that biological age, make it as predictive as possible. But as we go forward, I think the thing that we can do that that hasn't been done before is we are actually trying to score the actions in combination of actions that you are taking, not the user base, but you are taking. And so then, of course, across the database of all users, we can match you with people like you. So on all the attributes, not just not just your blood biomarkers or digital markers, but also your activity rates and other things. And we can start to actually learn across that, you know, bio twin or whatever you want to call it, of Harry, we can start to feed back to you, OK, you might want to try this action. You might want to do more of this action because it seems to be working on all your bio twins within the user base.Harry Glorikian: This is Harry again. Our Internet connection cut out one more time while Michael was explaining how the app will track users’ eating habits and nutrition. The basic idea is just that the app won’t be counting every meal or every calorie.Michael Geer: The focus will not be on trying to make sure that you tell us every single kind of vegetable portion that you that you give us. We're trying to be as agnostic as possible to the data we're taking in. And so if you are tracking that in quite detail in another app, you know, we're looking to hook in through APIs and through Apple Health with as many of those kind of apps so that your data doesn't replace. The biggest things that we'll be capturing is kind of the type of your diet, the frequency of your diet and kind of the time window. And those will be the main things that we come up in in the beginning. That's how do you make that less burdensome to the you know, because I think to myself I'm like, crap, I'm spending so much time, like trying to track everything that I mean, that's the thing. Right. And that's where Pete and I, my background is in. The good news is that a lot of this stuff is already quite well connected to most of the stuff we're collecting on you is automated. So you just go about your day and, you know, the data comes in. And so it's coming through your wearable right now, most of it. So we're building on iOS first, so all of that stuff's coming into your Apple Health. We pull it out of HealthKit and then you don't have to do anything as a user. You basically just see your points racking up and you can get guidance on what you can do to increase your score more. And we'll look to do that on everything that we're tracking, not just nutrition, but, you know, not just activity, but each thing that we start to expand and kind of we want to collect as much of your lifestyle actions as possible so that the model can learn from it and become more accurate.Harry Glorikian: So let's jump back for a second. Right. So. You're using all these older, you know, the Framingham heart study, et cetera, to build some sort of model that shows that with certain marker changes, biological age changes versus chronological age. But then is the assumption that you have to actually change some of those -- that you might be able to change that biological age?Michael Geer: Yeah, I mean, that's a that's exactly it. You basically have a, and this isn't new. Harry Glorikian: Oh, no, it's not it's definitely not new.Michael Geer: Certainly, you know, what I touch on is kind of the example of like the old ways. It's probably just more like the version one or two. And this is like the version three with cholesterol. You know that the reason why that became such a focus is because so many people that came in with heart attacks and when they started doing, you know, you know, bigger research studies as they saw that they had high cholesterol, it was like, you know, the person that was always in the room when the money got stolen kind of thing. Right. And so this is this is just expanding upon, that is you're looking at as many markers as you have in these longitudinal data sets and you're able to come up with a weighted probability of all the all the future diseases that ended up happening in that dataset, whether it be Framingham or NHANES or UK Biobank.Harry Glorikian: So is there, is there any data that, you know that that and maybe you guys are starting to generate it, but you know where this health monitoring service can change morbidity and mortality across killers like, you know, cardiovascular, metabolic, et cetera?Michael Geer: Yeah, the there's a lot of examples of it. There's I think the what we try to always do is keep it like the most highly accepted ones when we talk to talk to people about it. I think there's a lot of newer work that that's been very specific, but there's just a ton of work that actually led to all those recommendations that we ended up with anyway. Right. They would do kind of these is more controlled studies where, you know, this group would do this amount of exercise in this group wouldn't. And they tried to control for all the factors within those two groups. And so there's a there's a ton of kind of peer reviewed research studies that basically show that these different interventions actually did change the future health outcomes, whether, you know, reduce the occurrence of cancer or reduce the occurrence of heart attack. And so all these things have very much been proven. I think that thing, the new thing or the other thing that we're trying to really bring is not changing any of that. What we're trying to do is bring to consumers the ability to track it very closely, very accurately, and get that combinatorial, you know, of those actions. And so you could actually see like the like the example I was giving earlier, like better sleep plus the diet. Plus this amount of exercise is the perfect kind of optimal for you to really increase your health span. And that's the difference. I wouldn't say it's a difference in the accepted .... we never actually go into a room and kind of even like more traditional kind of, you know, on the on the medicine side, and no one really, as you said at all, these concepts are accepted already fully. It's more how do we actually deliver that to consumers at scale? And I think that's what we're that's what we're trying to tackle.Harry Glorikian: Yeah, that's what I was going to go to next, which is, you know, you and Peter have like a lot of experience on digital products and services used by hundreds of millions of people. Right. Do you feel like Humanity is scalable in the same way?Michael Geer: Yeah, and I think I think part of that is, is you start with the, I think I have a slide in one of my old presentations. I'll give it at conferences. The you know, you've got to, if you want a mainstream application that reaches hundreds of millions of people, you need to focus on a kind of a mainstream need for lack of a better word. You might say that Badoo, I would say Badoo kind of allowed you, the dating site that I that I started and the founding team, the you know, it allows you to meet new people. That was a tag line. But some would say, OK, it's sex. And so the sex sells, sex sells. So if you build something, you're probably going to get people to use it. And I think health is another one of those. Right. And I think that's. That makes us very optimistic that we can we can do it as long as we have the right team around us.Harry Glorikian: And that was going to be my next question. So. Right. So what evidence do you have the consumers are, you know, really motivated and of course, there's, look, you know, helping Evidation and, you know, talking to Christine, there's always a group of people, right, that that are incredibly motivated to do these things. But now are you're talking about a large mass of people. You're saying you've got to collect this data. It'll get better if you have a wearable. You know, you've got to take this blood work every three months. And how do you keep them going over time? Like, how do we know that they're motivated?Michael Geer: I think the thing that captures a lot of people's attention and captured me and paid attention and captures users' attention, and it sounds too simple to be true, but the actual focus on aging is very motivating. Just to give you a couple of anecdotes from our alpha users, you know, one of them, one of them saw her rate of aging and very soon after moved to another country where she could live in a place where she could go hiking a lot. We you know, we saw another person. We actually heard this a couple of times from users where they basically when they got their first rate of aging, they basically went for a run right afterward. Actually, this is the thing that's realistically going to make them younger. But the fact is that seeing your rate of aging as it kind of cuts through all the more nebulous stuff, when people say be healthier, you can say be healthier to a room of 10 people and they probably have, you know, 10 or eight different ideas of what that means. Right.Harry Glorikian: There was a video, I think that somebody created that, you know, you could put your picture in there and it would actually age you. And I think for a lot of younger people, it freaked them out, right, because they never think about it. And then to see yourself, maybe you guys need to add that as a part of the service. If you continue down this route, you could look like this.Michael Geer: And we will, because I think I think the other thing the other thing that you realize when you, there's things that need to be very strict and serious. Right. And there's but in that slide, the data that you present to the user, you know, the anything you present to the user that's about their health needs to be that. Right. But the way that you capture their attention and the way that you motivate them to do things outside of that first rule, you know, we need to use all the all the tricks that people all the kind of methods that people, you know, say are bad with Facebook or some other service. Like I think we all kind of agree, like it would be so much better if those methods were used to actually make us healthier and happier, rightHarry Glorikian: No, no. I mean, you know, we always found that gamification and reward systems and all those things that sort of motivate people to do things that they're critical to call it, changing a bad habit, right, and trying to motivate, you know, people to be healthier, I mean, I'm sure that there are physicians that are listening to this going, I can't get my patient to do what I need them to do. What are you guys talking about? But I think that some of these technologies and some of these interactivity of just nudging someone. You know, it does get them to think about things.Michael Geer: I think the, so the example that I always give is so when you come from the outside, let's say Pete and I are coming from the outside here. We're consumer tech folks. We there's never been a popular or, you know, mass scale product that didn't have feedback loops. And so when you go to and this isn't a criticism of the of the doctors, but it's just kind of a, you shouldn't expect something unless you have that feedback loop. So if you if you put a photo up on Facebook and no one likes it or comments on it, like how many more photos do you think that person is going to post on Facebook? None, right? It's you've got to have that feedback loop of, I did something and now I see the reaction. Right. And so when you go to a doctor like once a year and your doctor kind of looks at your chart and you're kind of like, you're ranging a little bit out of norm, but you're not doing anything critical. And they're like, you need to be healthier, you need to exercise more. And you're like and you probably leave that meeting with the doctor like semi-motivated or at least thinking about it. And then but what happens the next day? Like what happens if you go for a run and then what do you look at getting another blood test? You're not getting any kind of real feedback. And so getting the feedback loops really tight is you can't expect the motivation without it. And so that's kind of table stakes. And I think a lot of times people start to espouse that people are never going to be motivated. But it's the system needs to just be you know, it needs to be a better kind of loop created.Harry Glorikian: So how does how does a patient take this and then interact with their physician or the medical establishment or so forth?Michael Geer: Yeah, I mean, that's one of the one of the things we thought really deeply about is so when you're making something like this and anybody that is making any app or any kind of service that collects any biomarkers knows that you will come across things that, you know, need more attention or they seem like they need more attention. Right. And so one of the things that we already do is we do a kind of physician oversight on top of the blood markers before they come back into the system. And we basically triage people out to their GP and make sure that they can, you know, hand those results to the GP. We do that whole system to make sure that anything that looks like it might be further out of the norm is actually brought to the user's attention and they know the next step they should take. I think that can be done at an even more seamless level telemedicine and different things, you see this with, you know, genetic testing already in the consumer spaces, some of the better companies will set you up. So Color. This was even years ago when I did Color for the first time, which does, you know, cancer genetic markers. You know, that part of their service is you got a genetic counseling session. And I think that's what we touched on earlier about the kind of like funnel of preventative. And then when something might be detected, even, you know, that handoff.Harry Glorikian: Yeah. I mean, this thing here, it'll take my measurement for free. Yeah, exactly. But, you know, then it has the subscription service where there's a machine learning algorithm which will say something is wrong and then it'll elevated to a physician if, you know, if it's completely out of line. So I totally understand the process. But, so, what's the long-term vision? Is it a consumer product? Is it something where you're you know, you've got industry partnerships with either health care providers or insurers or drug developers? What's the plan?Michael Geer: Yeah, I think when we, when people that kind of did services that got to a larger level, the method that's in we'll use this on Humanity because it's worked for us so far is you start direct to consumer. You get that. Products. You want that that direct interchange with the consumer. Right. You then the next step is, it's a very easy step is to be to see or then other people that have connection with a lot of people then distribute your products directly to those other people. I think the bigger vision is where we got to kind of with AnchorFree, which is the consumer VPN that I that I help run out in the valley, which had 700 million people. As you start to actually try to lift and kind of effect the market as a as a whole set with the consumer vendors, we basically started refusing to allow any government agencies or anything to see our servers and we started to affect policy on a kind of a larger level and different countries in the sense of humanity. We want to be super open and collaborative. And so, you know, our model is, is consumer subscription model. We don't want to be, we don't we don't have a need to lock down IP. We don't have a need to you know, we're just doing a consumer. Then we're going to get IP, then we're going to have a license, licensing kind of model. Our mission is to have that kind of that subscription model bring as much value into the free portion so that it's as radically inclusive as possible and then preserving the privacy of that data, allow modeling on that data that can help raise all ships. And in the research space, it and that's yeah, that's kind of the five-year plan and probably that's the 15-year plan. But, you know, you see what happens as you go.Harry Glorikian: Awesome. Well, it was great to catch up with you and talk to you. Appreciate the time. I'm super curious to see how this evolution comes out and. You know, maybe one of these days we can hop on and, you know, if there's anonymized data, I'd love to see what you guys are seeing, always super interesting. So I actually look forward to it.Michael Geer: Thanks, Harry.Harry Glorikian: That’s it for this week’s show. We’ve made more than 50 episodes of MoneyBall Medicine, and you can find all of them at glorikian dot com forward-slash podcast. You can follow me on Twitter at hglorikian. If you like the show, please do us a favor and leave a rating and review at Apple Podcasts. Thanks, and we’ll be back soon with our next interview.

Kiribto Somali tv waa Goob Aad ka Baran Karto lacagaha dhijitaalka Ah iyo Tech, yada Blockchain cryptocurrency AfSomali ah waxaad kaloo nagala socan kartaa shabakada kiribto.com ama barteene youtubka www.youtube.com/c/KiribtoSomaliTv?sub_confirmation=1 isticmaal browserka amaanka ah ee xawaarihiisu sareeyo ee brave browser kala soo dag halkan brave.com/?ref=kir251 mahadsanid

We Rise has been partnering with Mycelium Youth Network for over a year, and together, we are so excited to share this two-part podcast series with you. Here is the first of two keynote speeches from MYN's Autumn 2020 conference entitled Apocalyptic Resilience: An Afro-Indigenous Futuristic Adventure. This first episode features the unstoppable Isha Clarke with Youth vs. Apocalypse, and Atekpatzin, indigenous educator (bios below).Mycelium Youth Network prepares young people for climate change, using a combination of our ancestral knowledge and practices, and the best of science technology engineering arts and math (STEAM) thinking. For the past year We Rise, MYN, and Bioneers have been collaborating to bring you an amazing project to support young people telling their stories of climate resilience and environmental justice. You can learn more and support the work by going to MyceliumYouthNetwork.org. Feel free to follow @MyceliumYouthNetwork on Facebook & Instagram and @MyceliumYouth on Twitter for more updates.Isha Clarke is a West Oakland resident, organizer, advocate, activist, and co-founder of Youth Vs Apocalypse. Isha is a recent high school graduate who was born, raised, and educated in West Oakland, CA. Isha recognizes that climate change is the consequence of fundamental systems of oppression like white supremacy, capitalism, and colonialism, and therefore, disproportionately impacts people of color, indigenous communities, and working-class people. Knowing this, Isha’s work is focused on building a movement that shapes the leadership of frontline communities, creates solidarity between other fights for justice, and works to dismantle the systems of oppression that fuel climate change. As a result of this work, Isha was awarded the 2019 Brower Youth Award, 2020 Diller Tikkun Olam Award, and has become a nationally recognized speaker, presenter, and writer.Atekpatzin Young is an independent researcher, consultant, writer, artist, and musician. Mr. Young has done extensive research on the Indigenous peoples of Tehuayo, Indetah and Aztlán and their present-day descendants. He has also studied the relationship of ancient and contemporary Nahua religious practices. He spent fifteen years studying with traditional Indigenous healers. Mr. Young is the recipient of the Martin Luther King, Jr. Scholarship award, and the Cesar Chavez Peace and Justice Leadership Award.Thank you to Dani Ahuicapahtzin Cornejo for generously contributing your music to this episode. Original music: Wayñumi Aswan Allin from new album Debajo del Agua.

Now that the Fall 2020 semester has wrapped up, Tom wanted to get a student's perspective of life on campus during a pandemic. Dr. Mitzel has a rather candid conversion with Wish Read, a History Major at Kentucky Wesleyan College.

Kiribto Somali tv waa Goob Aad ka Baran Karto lacagaha dhijitaalka Ah iyo Tech, yada Blockchain cryptocurrency AfSomali ah waxaad kaloo nagala socan kartaa shabakada kiribto.com ama barteene youtubka www.youtube.com/c/KiribtoSomaliTv?sub_confirmation=1 isticmaal browserka amaanka ah ee xawaarihiisu sareeyo ee brave browser kala soo dag halkan brave.com/?ref=kir251 mahadsanid

Wayn gives us an overview of the Mac. Comparing and explaining the learning curve experienced when transitioning to Windows. He explains some key concepts and key commands. Following are some great questions and further explanations by others. Information packed a   s always. Please reach out to Kim Kilpatrick for information regarding the book Wayn mentions

A first for the show, the same guest two weeks running. This time we tried to do the podcast intended for part one, did we succeed? I think so. We also discovered how good Erik is at reading and answering our listeners’ emails which we have cleverly called “Ask Erik”. From now on email reading and answering will be handled by someone who turns it into a kind of performance art.   Things we chatted about on the show:   “Rides Slow and Take Photos” web article for some background to Erik’s Butterfield overland mail trail bike ride. https://www.analogforevermagazine.com/features-interviews/film-review-ride-slow-take-pictures?fbclid=IwAR2EPCPIhFtwFzulEit7Jy-D2Qd7Ws3tnGSLIb3trteOZcprh_f1sTJqjNU   Erik sent us several links to things we chatted about on the show and some I don’t think we did! But they all look great.   The work of Consuelo Konaga whose archive is at the Brooklyn Museum. https://www.brooklynmuseum.org/opencollection/artists/6641/objects?fbclid=IwAR1YWwpKLgawjEQtplTwDCnpeH6Gp_mLul-TGBNLiwXz7xTRLBzesL9B4TY   At the end of Erik’s Butterfield bike ride he ends up at the workshop of Wayne Martin Belger, we chat a bit about Wayne’s “third Eye” skull camera and his “Us and Them” camera which is remarkable.  Erik drew our attention to Wayn’e ground breaking “HIV Bloodworks” project, here is a link. https://www.waynemartinbelger.com/index/G00008tmllFKMnBQ?fbclid=IwAR31KEj8oM0Gj5WLSkk9_zYzsZ1yiicCfZAPJQWJ5hZIJL2UnnkLnBNDCR8   Eric said “Also, I didn’t touch on him but I wanted to. Josef Koudelka’s “Black Triangle” was the first set of landscapes I’d ever seen that were both stunningly beautiful and incredibly hard hitting from a documentary perspective. https://www.magnumphotos.com/newsroom/environment/josef-koudelka-black-triangle/?fbclid=IwAR31KEj8oM0Gj5WLSkk9_zYzsZ1yiicCfZAPJQWJ5hZIJL2UnnkLnBNDCR8   Josef uses the Fuji 617 panoramic camera to brilliant effect. He produced a book called Ruin and has completed a documentary as well. https://www.magnumphotos.com/theory-and-practice/koudelka-shooting-holy-land-israel-palestine-documentary-conflict/?fbclid=IwAR0I6xjWbYmrNIPRqouTOWr3UJCRV4DNMHY1YuLSMDG2AA3rfjmVKYW8Tig   Erik gives a shout out to artist and activist Lucinda Hinojos who he meets on his trip. This was made on his Graphic and dollar bill lens after Erik cracked a joke! Follow Lucinda on her IG https://www.instagram.com/lucinda_yrene/?fbclid=IwAR2993uQuMZHdu0E0w3vUTkrKbZ8VAKdtlZgkU92oWM26E8wTKLDcAM6XUY   Fred at SurplusShed.com can get you ANY lens element and more. He sounds amazing. https://www.surplusshed.com/     Erik’s links A not updated website. https://www.erikmathy.com/about   IG probably best for all things including rabbits. https://www.instagram.com/erikhmathy/?hl=en     Phew   Other News   The Six Towns Darkroom is OPEN but if you want to come along please get in touch with Simon first as numbers are limited.     LFPP links -   https://largeformatphotographypodcast.podbean.com/   ko-fi.com/largeformatphotographypodcast   You can join in the fun at our Facebook Group https://www.facebook.com/groups/2296599290564807/   And now our Flikr group curated by Colin Devroe https://www.flickr.com/groups/lfpp/   Get Twitter updates for the show from Andrew – https://twitter.com/warboyssnapper   Or from Simon – https://twitter.com/simonfor   Email feedback, ideas and questions for the podcast largeformatphotographypodcast@gmail.com   Podcast Hosts Social Media presence   Simon Forster www.classiclensespodcast.com   www.simonforsterphotographic.co.uk   https://stores.ebay.co.uk/itsfozzyphotography   https://www.flickr.com/photos/125323761@N07/   https://www.facebook.com/SimonForsterPhotographic/   https://www.instagram.com/simonforsterphotographic/   https://twitter.com/SimonFor   Andrew Bartram https://anchor.fm/thelenslesspodcast   https://andrewbartram.wordpress.com   https://www.instagram.com/warboyssnapper   https://www.imstagram.com/warboyssnapper_pinholes   https://www.flickr.com/photos/warboyssnapper/   https://twitter.com/warboyssnapper

Welcome to the GIANT Thinking podcast. A show that is passionately committed to bringing you conversations with the leading experts who are improving the health and wellbeing of people around the world by supporting innovation and accelerating the adoption of new healthcare technology. In this episode GIANT Health (Global Innovation And New Technology) CEO Barry Shrier welcomes Peter Ward; successful CEO, investor, entrepreneur and advisor. Having successfully built and sold travel brand WAYN (which was acquired by lastminute.com Group) Peter has turned his attention and vast skillsets to the healthcare sector, co-founding Humanity which will be a subscription platform that allows you to monitor biomarkers that are closely connected to loss of function in different parts of the body over time (ageing).  Subjects covered in this episode: * The advancement of Biomarker technology * The importance of measurement for ensuring longevity * The essential role that wearable technology can have * How low-cost tech can have a real impact on global wellbeing * Why a concrete feedback loop is essential for preventative care As always, this is an important conversation on essential subjects with leading experts, this is GIANT thinking. SUBSCRIBE now to ensure you never miss an episode.

North Pacific, Master Of Wine, Masked Crusader, Doubtland … Team Hawkes look set for a huge spring. Wayne Hawkes joined RSN Central for this weeks edition of Wayn'es World.

God uses trials to open our understanding of where we need to change in order to come into full alignment with his Word.  Coming into full alignment with His Word opens up God's promises to us more exceedingly and abundantly that we could ever imagine!      

Muranka doorasahda Soomaaliya ayaa wali socda iyadoo aan la ogayn nooca iyo waqtiga uu dhacayo.

Kiribto Somali tv waa Goob Aad ka Baran Karto lacagaha dhijitaalka Ah iyo Tech, yada Blockchain cryptocurrency AfSomali ah

Sam talks with Nigel Eccles about his new company Flick. A companion app for sports fans who want to watch a game while chatting online with likeminded fans and friends.Nigel talks about how Flick has raised £4m and was growing nicely until Covid-19 put a stop to all live sports. He believes Flick will return to growth once live sports like football return. In fact with stadium bans it could see ever greater demand for Flick as fans try to recreate the stadium atmosphere while at home.Prior to Flick, Nigel, his wife and three engineers started Hubdub that soon pivoted into FanDuel. Nigel recalls how a WebMission to Silicon Valley in 2008 helped Fanduel grow. Some of the other companies that joined them included edocr, huddle, skimlinks, mydeo, WAYN and TrustedPlaces.Nigel talks about how FanDuel went on to raise $450m+ and experienced hyper-growth in customer acquisition. Sadly the story did not end up with Nigel and his wife growing a Unicorn, selling it and riding off into the sunset. Nigel talks at length about how the Private Equity company engineered to remove him, the executive team and all the staff who held ordinary shares from benefiting from their growth and success. In fact they ended up with zero while the board that consisted of the PE Equity partners engineered it to make themselves millions.The story does not end there. Nigel and 90 of his original staff have filed a class action suit against the PE company. We await the outcome.

Part One:   (Total Time:     11:25) Karen’s journey growing up in Detroit and going to school at Wayne State. The collage years working at WAYN, WDTE and WWWW. Karen’s four years at W4 and three at WABX leading to her spot at WRIF.  Part Two:   (Total Time:     25:27) Working in the old broadcast trailer and the 80s all-star lineup at the Riff. Karen’s long relationship with Bob Seger, having dinner with Queen and seeing The Who at the Silverdome. Part Three:   (Total Time:     38:11) Working with J., George, Ken Calvert, Arthur P. and Steve Kostan. A short run doing the morning show on WRIF with Lynne Woodison. Seeing Eric Clapton and Joe Cocker at the old Eastown and being recruited to WCSX.  Part Four:   (Total Time:     42:44) The Van Halen interview that included the whole band and a few strippers.

WAYN (Where Are You Now?) was founded by three young entrepreneurs with a simple concept: create a platform for travelers to connect when on the road.The U.K.-based brand was a pioneering travel social network that captured a huge amount of attention in the mid-2000s for its rapid growth, bold ideas and ability to attract investment from some of the biggest names in the online travel industry at the time.Millions of users and a youthful, fairly brash style inspired a string of fellow social travel platforms in subsequent years (whether those later founders will admit it or not).But the company was inevitably going to find the road would be a bumpy one, with the emergence and omnipresence of Facebook in the world of social networks and a tactical error or two along the way.After the buzz turned to the reality of maintaining a business in a digital market that was continually evolving, WAYN was eventually sold to Lastminute.com Group in 2016.Co-CEO Jerome Touze (his fellow boss was Pete Ward) tells the story of WAYN in the latest episode of How I Got Here.HIGH is a weekly show produced by PhocusWire and Mozio, aimed at getting the inside stories behind startups and innovation in travel and transportation.Other episodes: on PhocusWire and Mozio.

Warar iyo Barnaamijyo Af Soomali ah

Warar iyo Barnaamijyo Af Soomali ah

Gary Wayne author of genesis 6 conspiracy is joining us again this time to dive into the topic of faries! We are going to discuss the different types and the proof of their existence going back and tracking heritage through the bible.

Tom Impallomeni is CEO & Co-Founder of Tribe VR. Tribe VR is a San Francisco-based VR development startup concentrating on immersive learning applications for virtual and augmented reality to enable users to learn real-world skills.Prior to Tribe, Tom built up extensive experience with startups such as SuperAwesome, Virtually Live and WAYN.com. Tom is an adviser to a Aflete, FireTech Camp and Pyramind. In his spare time, he's a dad to three girls, a long-suffering Tottenham Hotspur fan and spends most of his days listening to house music playlists on Spotify. If you would like more information on Tom please check out the following links below:Tribe VR - https://www.tribevr.io/Tom's LinkedIn - https://www.linkedin.com/in/tomimpallomeni/Tom's Twitter - https://twitter.com/tomimpallomeniHumans 2.0 Twitter - https://twitter.com/Humans2PodcastYouTube - http://bit.ly/2xk3a9UTwitter - https://twitter.com/markymetryMedium - https://medium.com/@markymetryFacebook - https://www.facebook.com/mark.metry.9Instagram - https://www.instagram.com/markmetry/My Website - https://www.markmetry.com/

Tom Impallomeni is CEO & Co-Founder of Tribe VR. Tribe VR is a San Francisco-based VR development startup concentrating on immersive learning applications for virtual and augmented reality to enable users to learn real-world skills.Prior to Tribe, Tom built up extensive experience with startups such as SuperAwesome, Virtually Live and WAYN.com. Tom is an adviser to a Aflete, FireTech Camp and Pyramind. In his spare time, he's a dad to three girls, a long-suffering Tottenham Hotspur fan and spends most of his days listening to house music playlists on Spotify. If you would like more information on Tom please check out the following links below:Tribe VR - https://www.tribevr.io/Tom's LinkedIn - https://www.linkedin.com/in/tomimpallomeni/Tom's Twitter - https://twitter.com/tomimpallomeniHumans 2.0 Twitter - https://twitter.com/Humans2PodcastYouTube - http://bit.ly/2xk3a9UTwitter - https://twitter.com/markymetryMedium - https://medium.com/@markymetryFacebook - https://www.facebook.com/mark.metry.9Instagram - https://www.instagram.com/markmetry/My Website - https://www.markmetry.com/

On this episode of Worst Millennials, Damon talks with his good friend and host of WAYN Radio’s The Aux Cord, Shay Franchini, about Podbros Network, his experiences at Wayne State University, and PechaKucha Night Detroit on April 7th.  This is arguably the first and last PG Edition of Worst Millennials. More info about PechaKucha Night […]

Resurrection Revealed podcast produced by http://MediaVoiceOvers.com for http://ResurrectionRevealed.com / / If you enjoy the Resurrection Revealed podcast, you can help support my efforts in a variety of ways (your choice): / / 1) Please consider Wayn

Himiga wayn

Feat: Drake, Nicki Minaj, Lil wayne , Dj Khalid, T.I, 50 Cent, Future and More

This episode hosted by Aeraphis of First image/ University Of Concrete features unsigned artist Illiteracy, Brett Carol, Lyrical Lee, Stix, Np Hozman, Deuce Broadway, Chezdo Valentine, Joey Carmels, V Henny, and Don Rojo Art work by joseph Meloy

Matt Jerwood, Director of Business Development, WAYN

W tej niezwykłej, rozciągniętej na setki lat sadze, narysowanej przez trzech niesamowitych artystów poznamy losy Joshuy – protoplasty rodu, życie i śmierć Bruce’a oraz perypetie Brenny, spadkobierczyni fortuny Waynów. Kilka uwag godai’ego n/t komiksu: Dark Knight Dynasty scenariusz: Mike W. Barr grafika: Scott Hampton, Gary Frank, Cam Smith, Scott McDaniel, Bill Sienkiewicz kolor: Ian Hannin, […]